GABA-A vs GABA-B receptors
The brain's two brakes: one fast (ionotropic) and one slow (metabotropic)
Definition
GABA (gamma-aminobutyric acid) is the brain's principal inhibitory neurotransmitter, and it acts on two very different receptor families. GABA-A receptors are ionotropic: ligand-gated chloride channels that mediate fast inhibition (milliseconds) by hyperpolarizing the neuron. GABA-B receptors are metabotropic: G-protein-coupled receptors that produce slower, longer-lasting inhibition by opening potassium channels and inhibiting calcium channels. Telling them apart is key to understanding the sleep, anxiety and neurochemical calm that longevity protocols aim for.
Detailed explanation
The functional difference is mechanistic. The GABA-A receptor is a pentamer forming a central pore selective for chloride; when GABA binds, chloride flows in, the neuron hyperpolarizes and the signal shuts off within milliseconds. This receptor is the target of benzodiazepines, barbiturates, ethanol, anesthetics (propofol) and neurosteroids — all allosteric modulators that potentiate endogenous GABA rather than replacing it.
The GABA-B receptor, by contrast, is an obligate heterodimer (GABA-B1 and GABA-B2 subunits) of the GPCR superfamily; its discovery as a functional dimer revolutionized the field. On activation it couples Gi/Go proteins that open GIRK potassium channels (sustained hyperpolarization) and inhibit voltage-gated calcium channels (reduced neurotransmitter release). Its effect is slower (hundreds of milliseconds to seconds) and modulates tone rather than a single spike. Baclofen is its prototypical clinical agonist.
This duality explains why oral GABA has limited central effects (poor blood-brain barrier penetration) while GABAergic modulators remain mainstays for insomnia, anxiety, epilepsy and spasticity.
Scientific sources
Interested in related treatments?
Generate My Protocol